In rhabdomyosarcoma (RMS) cells, genetic knockdown of PKCα, Gö6976 (a PKCα and PKCβ selective inhibitor), and bisindolylmaleimide I (a pan-PKC inhibitor) suppressed Erastin-caused ferroptosis of RMS cells [14]. The gene discussed is PRRT2; the disease is rhabdomyosarcoma.